Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson&amp;rsquo;s disease dementia

Public

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Shared by NobleBlocks on Apr 1, 2017 • 12:00 AM UTC

Authors:

Nagaendran Kandiah

Ming-Chyi Pai

Vorapun Senanarong

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!